NF-κB, inflammation, immunity and cancer: coming of age (original) (raw)

• Balkwill, F. & Mantovani, A. Inflammation and cancer: back to Virchow? Lancet 357, 539–545 (2001).
  CAS PubMed Google Scholar
• Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860–867 (2002).
  CAS PubMed PubMed Central Google Scholar
• Fujiki, H. Gist of Dr. Katsusaburo Yamagiwa's papers entitled “Experimental study on the pathogenesis of epithelial tumors” (I to VI reports). Cancer Sci. 105, 143–149 (2014).
  CAS PubMed PubMed Central Google Scholar
• Greten, F. R. et al. IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118, 285–296 (2004).
  CAS PubMed Google Scholar
• Pikarsky, E. et al. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 431, 461–466 (2004). References 4 and 5 are the first reports to identify NF-κB as a central player that links inflammation to cancer.
  CAS PubMed Google Scholar
• Kuper, H., Adami, H. O. & Trichopoulos, D. Infections as a major preventable cause of human cancer. J. Intern. Med. 248, 171–183 (2000).
  CAS PubMed Google Scholar
• Plummer, M. et al. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob. Health 4, e609–e616 (2016).
  PubMed Google Scholar
• Grivennikov, S. I., Greten, F. R. & Karin, M. Immunity, inflammation, and cancer. Cell 140, 883–899 (2010). Reference 8 is an excellent comprehensive review that describes the roles of inflammation and immunity in cancer.
  CAS PubMed PubMed Central Google Scholar
• Calle, E. E., Rodriguez, C., Walker-Thurmond, K. & Thun, M. J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U. S. adults. N. Engl. J. Med. 348, 1625–1638 (2003).
  PubMed Google Scholar
• Shalapour, S. & Karin, M. Immunity, inflammation, and cancer: an eternal fight between good and evil. J. Clin. Invest. 125, 3347–3355 (2015).
  PubMed PubMed Central Google Scholar
• Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011). This review describes the ten hallmarks of cancer.
  Article CAS PubMed Google Scholar
• Karin, M. & Clevers, H. Reparative inflammation takes charge of tissue regeneration. Nature 529, 307–315 (2016). This review describes how inflammation regulates tissue regeneration.
  CAS PubMed PubMed Central Google Scholar
• Sen, R. & Baltimore, D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46, 705–716 (1986).
  CAS PubMed Google Scholar
• Zhang, Q., Lenardo, M. J. & Baltimore, D. 30 Years of NF-κB: a blossoming of relevance to human pathobiology. Cell 168, 37–57 (2017).
  CAS PubMed PubMed Central Google Scholar
• Karin, M. Nuclear factor-κB in cancer development and progression. Nature 441, 431–436 (2006).
  CAS PubMed Google Scholar
• Perkins, N. D. The diverse and complex roles of NF-κB subunits in cancer. Nat. Rev. Cancer 12, 121–132 (2012).
  CAS PubMed Google Scholar
• Karin, M. & Greten, F. R. NF-κB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5, 749–759 (2005).
  CAS PubMed Google Scholar
• Staudt, L. M. Oncogenic activation of NF-κB. Cold Spring Harb. Perspect. Biol. 2, a000109 (2010).
  PubMed PubMed Central Google Scholar
• Ben-Neriah, Y. & Karin, M. Inflammation meets cancer, with NF-κB as the matchmaker. Nat. Immunol. 12, 715–723 (2011).
  CAS PubMed Google Scholar
• DiDonato, J. A., Mercurio, F. & Karin, M. NF-κB and the link between inflammation and cancer. Immunol. Rev. 246, 379–400 (2012).
  PubMed Google Scholar
• Terzic, J., Grivennikov, S., Karin, E. & Karin, M. Inflammation and colon cancer. Gastroenterology 138, 2101–2114 (2010).
  CAS PubMed Google Scholar
• Lasry, A., Zinger, A. & Ben-Neriah, Y. Inflammatory networks underlying colorectal cancer. Nat. Immunol. 17, 230–240 (2016).
  CAS PubMed Google Scholar
• West, N. R., McCuaig, S., Franchini, F. & Powrie, F. Emerging cytokine networks in colorectal cancer. Nat. Rev. Immunol. 15, 615–629 (2015). References 22 and 23 are excellent Reviews that describe the roles of inflammation and cytokines in colorectal cancer.
  CAS PubMed Google Scholar
• Grivennikov, S. I. et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 491, 254–258 (2012).
  CAS PubMed PubMed Central Google Scholar
• Wang, K. et al. Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis. Immunity 41, 1052–1063 (2014). References 24 and 25 reveal how 'tumour-elicited inflammation' is induced and promotes tumorigenesis in spontaneous colorectal cancer.
  CAS PubMed PubMed Central Google Scholar
• Schwitalla, S. et al. Loss of p53 in enterocytes generates an inflammatory microenvironment enabling invasion and lymph node metastasis of carcinogen-induced colorectal tumors. Cancer Cell 23, 93–106 (2013). This study shows that loss of p53 in IECs results in NF-κB activation.
  CAS PubMed Google Scholar
• Vallabhapurapu, S. & Karin, M. Regulation and function of NF-κB transcription factors in the immune system. Annu. Rev. Immunol. 27, 693–733 (2009).
  CAS PubMed Google Scholar
• Sun, S. C. The non-canonical NF-κB pathway in immunity and inflammation. Nat. Rev. Immunol. 17, 545–558 (2017).
  CAS PubMed PubMed Central Google Scholar
• Bonizzi, G. & Karin, M. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25, 280–288 (2004).
  CAS PubMed Google Scholar
• Vallabhapurapu, S. et al. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling. Nat. Immunol. 9, 1364–1370 (2008).
  CAS PubMed PubMed Central Google Scholar
• Senftleben, U. et al. Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway. Science 293, 1495–1499 (2001).
  CAS PubMed Google Scholar
• Grivennikov, S. I. & Karin, M. Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev. 21, 11–19 (2010).
  CAS PubMed Google Scholar
• Oeckinghaus, A., Hayden, M. S. & Ghosh, S. Crosstalk in NF-κB signaling pathways. Nat. Immunol. 12, 695–708 (2011).
  CAS PubMed Google Scholar
• Zhong, B., Tien, P. & Shu, H. B. Innate immune responses: crosstalk of signaling and regulation of gene transcription. Virology 352, 14–21 (2006).
  CAS PubMed Google Scholar
• Ruland, J. Return to homeostasis: downregulation of NF-κB responses. Nat. Immunol. 12, 709–714 (2011).
  CAS PubMed Google Scholar
• Luo, J. L., Kamata, H. & Karin, M. IKK/NF-κB signaling: balancing life and death — a new approach to cancer therapy. J. Clin. Invest. 115, 2625–2632 (2005).
  CAS PubMed PubMed Central Google Scholar
• Xu, G. et al. Crystal structure of inhibitor of κB kinase β. Nature 472, 325–330 (2011).
  CAS PubMed PubMed Central Google Scholar
• Rothwarf, D. M. & Karin, M. The NF-κB activation pathway: a paradigm in information transfer from membrane to nucleus. Sci STKE 1999, RE1 (1999).
  CAS PubMed Google Scholar
• Chen, Z. J. Ubiquitination in signaling to and activation of IKK. Immunol. Rev. 246, 95–106 (2012).
  PubMed PubMed Central Google Scholar
• Tokunaga, F. & Iwai, K. LUBAC, a novel ubiquitin ligase for linear ubiquitination, is crucial for inflammation and immune responses. Microbes Infect. 14, 563–572 (2012).
  CAS PubMed Google Scholar
• Ma, X., Becker Buscaglia, L. E., Barker, J. R. & Li, Y. MicroRNAs in NF-κB signaling. J. Mol. Cell. Biol. 3, 159–166 (2011).
  CAS PubMed PubMed Central Google Scholar
• Boldin, M. P. & Baltimore, D. MicroRNAs, new effectors and regulators of NF-κB. Immunol. Rev. 246, 205–220 (2012).
  PubMed Google Scholar
• Taganov, K. D., Boldin, M. P., Chang, K. J. & Baltimore, D. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl Acad. Sci. USA 103, 12481–12486 (2006).
  CAS PubMed PubMed Central Google Scholar
• Iliopoulos, D., Hirsch, H. A. & Struhl, K. An epigenetic switch involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 139, 693–706 (2009).
  CAS PubMed PubMed Central Google Scholar
• Bretz, N. P. et al. Body fluid exosomes promote secretion of inflammatory cytokines in monocytic cells via Toll-like receptor signaling. J. Biol. Chem. 288, 36691–36702 (2013).
  CAS PubMed PubMed Central Google Scholar
• Ghosh, A. et al. Telomerase directly regulates NF-κB-dependent transcription. Nat. Cell Biol. 14, 1270–1281 (2012). This study reveals the association between telomerase and NF-κB.
  CAS PubMed Google Scholar
• Taniguchi, K., Yamachika, S., He, F. & Karin, M. p62/SQSTM1 — Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer. FEBS Lett. 590, 2375–2397 (2016).
  CAS PubMed PubMed Central Google Scholar
• Greten, F. R. et al. NF-κB is a negative regulator of IL-1β secretion as revealed by genetic and pharmacological inhibition of IKKβ. Cell 130, 918–931 (2007).
  CAS PubMed PubMed Central Google Scholar
• Zhong, Z. et al. NF-κB restricts inflammasome activation via elimination of damaged mitochondria. Cell 164, 896–910 (2016). Reference 48 reports an unanticipated role of NF-κB as a negative regulator of inflammation, and reference 49 reveals the mechanism of how NF-κB suppresses inflammation.
  CAS PubMed PubMed Central Google Scholar
• Atretkhany, K. N., Drutskaya, M. S., Nedospasov, S. A., Grivennikov, S. I. & Kuprash, D. V. Chemokines, cytokines and exosomes help tumors to shape inflammatory microenvironment. Pharmacol. Ther. 168, 98–112 (2016).
  CAS PubMed Google Scholar
• Quail, D. F. & Joyce, J. A. Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 19, 1423–1437 (2013).
  CAS PubMed PubMed Central Google Scholar
• Martinez, F. O. & Gordon, S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 6, 13 (2014).
  Google Scholar
• Sica, A. & Mantovani, A. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 122, 787–795 (2012).
  CAS PubMed PubMed Central Google Scholar
• Murray, P. J. Macrophage polarization. Annu. Rev. Physiol. 79, 541–566 (2017).
  CAS PubMed Google Scholar
• Porta, C. et al. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor κB. Proc. Natl Acad. Sci. USA 106, 14978–14983 (2009).
  CAS PubMed PubMed Central Google Scholar
• Hagemann, T. et al. “Re-educating” tumor-associated macrophages by targeting NF-κB. J. Exp. Med. 205, 1261–1268 (2008).
  CAS PubMed PubMed Central Google Scholar
• Ma, Y., Shurin, G. V., Peiyuan, Z. & Shurin, M. R. Dendritic cells in the cancer microenvironment. J. Cancer 4, 36–44 (2013).
  CAS PubMed Google Scholar
• Karyampudi, L. et al. PD-1 blunts the function of ovarian tumor-infiltrating dendritic cells by inactivating NF-κB. Cancer Res. 76, 239–250 (2016).
  CAS PubMed Google Scholar
• Tu, S. et al. Overexpression of interleukin-1β induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell 14, 408–419 (2008).
  CAS PubMed PubMed Central Google Scholar
• Vivier, E., Tomasello, E., Baratin, M., Walzer, T. & Ugolini, S. Functions of natural killer cells. Nat. Immunol. 9, 503–510 (2008).
  CAS PubMed Google Scholar
• Zhou, J., Zhang, J., Lichtenheld, M. G. & Meadows, G. G. A role for NF-κB activation in perforin expression of NK cells upon IL-2 receptor signaling. J. Immunol. 169, 1319–1325 (2002).
  CAS PubMed Google Scholar
• Huang, C. et al. A novel NF-κB binding site controls human granzyme B gene transcription. J. Immunol. 176, 4173–4181 (2006).
  CAS PubMed Google Scholar
• Ward, J. P., Gubin, M. M. & Schreiber, R. D. The role of neoantigens in naturally occurring and therapeutically induced immune responses to cancer. Adv. Immunol. 130, 25–74 (2016).
  CAS PubMed PubMed Central Google Scholar
• Gerondakis, S. & Siebenlist, U. Roles of the NF-κB pathway in lymphocyte development and function. Cold Spring Harb. Perspect. Biol. 2, a000182 (2010).
  PubMed PubMed Central Google Scholar
• Gerondakis, S., Fulford, T. S., Messina, N. L. & Grumont, R. J. NF-κB control of T cell development. Nat. Immunol. 15, 15–25 (2014).
  CAS PubMed Google Scholar
• Oh, H. et al. An NF-κB transcription-factor-dependent lineage-specific transcriptional program promotes regulatory T cell identity and function. Immunity 47, 450–465 (2017).
  CAS PubMed PubMed Central Google Scholar
• Shang, B., Liu, Y., Jiang, S. J. & Liu, Y. Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis. Sci. Rep. 5, 15179 (2015).
  CAS PubMed PubMed Central Google Scholar
• Grinberg-Bleyer, Y. et al. NF-κB c-Rel Is Crucial for the Regulatory T Cell Immune Checkpoint in Cancer. Cell 170, 1096–1108 (2017). Reference 68 shows that REL deletion or inhibition in T reg cells potentiates anti-PD1 therapy and suppresses tumour growth.
  CAS PubMed PubMed Central Google Scholar
• Gerondakis, S. et al. NF-κB subunit specificity in hemopoiesis. Immunol. Rev. 246, 272–285 (2012).
  PubMed Google Scholar
• Evaristo, C. et al. Cutting edge: engineering active IKKβ in T cells drives tumor rejection. J. Immunol. 196, 2933–2938 (2016).
  CAS PubMed Google Scholar
• Hopewell, E. L. et al. Lung tumor NF-κB signaling promotes T cell-mediated immune surveillance. J. Clin. Invest. 123, 2509–2522 (2013).
  CAS PubMed PubMed Central Google Scholar
• Giampazolias, E. et al. Mitochondrial permeabilization engages NF-κB-dependent anti-tumour activity under caspase deficiency. Nat. Cell Biol. 19, 1116–1129 (2017).
  CAS PubMed PubMed Central Google Scholar
• Ammirante, M., Luo, J. L., Grivennikov, S., Nedospasov, S. & Karin, M. B-Cell-derived lymphotoxin promotes castration-resistant prostate cancer. Nature 464, 302–305 (2010).
  CAS PubMed PubMed Central Google Scholar
• Ammirante, M. et al. An IKKα-E2F1-BMI1 cascade activated by infiltrating B cells controls prostate regeneration and tumor recurrence. Genes Dev. 27, 1435–1440 (2013).
  CAS PubMed PubMed Central Google Scholar
• Ammirante, M., Shalapour, S., Kang, Y., Jamieson, C. A. & Karin, M. Tissue injury and hypoxia promote malignant progression of prostate cancer by inducing CXCL13 expression in tumor myofibroblasts. Proc. Natl Acad. Sci. USA 111, 14776–14781 (2014).
  CAS PubMed PubMed Central Google Scholar
• Shalapour, S. et al. Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy. Nature 521, 94–98 (2015). This is the first report to describe IgA+ immunosuppressive plasma cells, which suppress CTL activation.
  CAS PubMed PubMed Central Google Scholar
• Kalluri, R. The biology and function of fibroblasts in cancer. Nat. Rev. Cancer 16, 582–598 (2016).
  CAS PubMed Google Scholar
• Koliaraki, V., Pallangyo, C. K., Greten, F. R. & Kollias, G. Mesenchymal cells in colon cancer. Gastroenterology 152, 964–979 (2017).
  CAS PubMed Google Scholar
• Erez, N., Truitt, M., Olson, P., Arron, S. T. & Hanahan, D. Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-κB-dependent manner. Cancer Cell 17, 135–147 (2010).
  CAS PubMed Google Scholar
• Calon, A. et al. Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation. Cancer Cell 22, 571–584 (2012).
  CAS PubMed PubMed Central Google Scholar
• Pallangyo, C. K., Ziegler, P. K. & Greten, F. R. IKKβ acts as a tumor suppressor in cancer-associated fibroblasts during intestinal tumorigenesis. J. Exp. Med. 212, 2253–2266 (2015).
  CAS PubMed PubMed Central Google Scholar
• Koliaraki, V., Pasparakis, M. & Kollias, G. IKKβ in intestinal mesenchymal cells promotes initiation of colitis-associated cancer. J. Exp. Med. 212, 2235–2251 (2015).
  CAS PubMed PubMed Central Google Scholar
• Grivennikov, S. I. & Karin, M. Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage. Ann. Rheum. Dis. 70, i104–i108 (2011).
  CAS PubMed Google Scholar
• Balkwill, F. Tumour necrosis factor and cancer. Nat. Rev. Cancer 9, 361–371 (2009). Reference 84 is an excellent comprehensive Review on the role of TNF in cancer.
  CAS PubMed Google Scholar
• Taniguchi, K. & Karin, M. IL-6 and related cytokines as the critical lynchpins between inflammation and cancer. Semin. Immunol. 26, 54–74 (2014). Reference 85 is a comprehensive review on the role of the IL-6 family of cytokines in solid malignancies.
  CAS PubMed Google Scholar
• Elmore, S. Apoptosis: a review of programmed cell death. Toxicol. Pathol. 35, 495–516 (2007).
  CAS PubMed PubMed Central Google Scholar
• Vanden Berghe, T., Linkermann, A., Jouan-Lanhouet, S., Walczak, H. & Vandenabeele, P. Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat. Rev. Mol. Cell Biol. 15, 135–147 (2014).
  CAS PubMed Google Scholar
• Pasparakis, M. & Vandenabeele, P. Necroptosis and its role in inflammation. Nature 517, 311–320 (2015).
  CAS PubMed Google Scholar
• Voronov, E. & Apte, R. N. IL-1 in colon inflammation, colon carcinogenesis and invasiveness of colon cancer. Cancer Microenviron 8, 187–200 (2015).
  CAS PubMed PubMed Central Google Scholar
• Garlanda, C., Dinarello, C. A. & Mantovani, A. The interleukin-1 family: back to the future. Immunity 39, 1003–1018 (2013).
  CAS PubMed PubMed Central Google Scholar
• Lu, B., Yang, M. & Wang, Q. Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy. J. Mol. Med. 94, 535–543 (2016).
  CAS PubMed Google Scholar
• Liew, F. Y., Girard, J. P. & Turnquist, H. R. Interleukin-33 in health and disease. Nat. Rev. Immunol. 16, 676–689 (2016).
  CAS PubMed Google Scholar
• Ali, S. et al. The dual function cytokine IL-33 interacts with the transcription factor NF-κB to dampen NF-κB-stimulated gene transcription. J. Immunol. 187, 1609–1616 (2011).
  CAS PubMed Google Scholar
• Choi, Y. S. et al. Nuclear IL-33 is a transcriptional regulator of NF-κB p65 and induces endothelial cell activation. Biochem. Biophys. Res. Commun. 421, 305–311 (2012).
  CAS PubMed Google Scholar
• Croxford, A. L., Kulig, P. & Becher, B. IL-12-and IL-23 in health and disease. Cytokine Growth Factor Rev. 25, 415–421 (2014).
  CAS PubMed Google Scholar
• Song, X. & Qian, Y. IL-17 family cytokines mediated signaling in the pathogenesis of inflammatory diseases. Cell Signal. 25, 2335–2347 (2013).
  CAS PubMed Google Scholar
• Yang, B. et al. The role of interleukin 17 in tumour proliferation, angiogenesis, and metastasis. Mediators Inflamm. 2014, 623759 (2014).
  PubMed PubMed Central Google Scholar
• Chang, Q., Daly, L. & Bromberg, J. The IL-6 feed-forward loop: a driver of tumorigenesis. Semin. Immunol. 26, 48–53 (2014).
  CAS PubMed Google Scholar
• He, G. et al. Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling. Cell 155, 384–396 (2013).
  CAS PubMed PubMed Central Google Scholar
• Taniguchi, K. et al. A gp130-Src-YAP module links inflammation to epithelial regeneration. Nature 519, 57–62 (2015).
  CAS PubMed PubMed Central Google Scholar
• Taniguchi, K. et al. YAP-IL-6ST autoregulatory loop activated on APC loss controls colonic tumorigenesis. Proc. Natl Acad. Sci. USA 114, 1643–1648 (2017). References 100 and 101 reveal that the SRC–YAP pathway links inflammation to tissue regeneration and plays an important role in colorectal cancer.
  CAS PubMed PubMed Central Google Scholar
• Tian, G., Li, J. L., Wang, D. G. & Zhou, D. Targeting IL-10 in auto-immune diseases. Cell Biochem. Biophys. 70, 37–49 (2014).
  CAS PubMed Google Scholar
• Lim, C. & Savan, R. The role of the IL-22/IL-22R1 axis in cancer. Cytokine Growth Factor Rev. 25, 257–271 (2014).
  CAS PubMed Google Scholar
• Meulmeester, E. & Ten Dijke, P. The dynamic roles of TGF-β in cancer. J. Pathol. 223, 205–218 (2011).
  CAS PubMed Google Scholar
• Richmond, A. Nf-κB, chemokine gene transcription and tumour growth. Nat. Rev. Immunol. 2, 664–674 (2002).
  CAS PubMed PubMed Central Google Scholar
• Chow, M. T. & Luster, A. D. Chemokines in cancer. Cancer Immunol. Res. 2, 1125–1131 (2014).
  CAS PubMed PubMed Central Google Scholar
• Weitzenfeld, P. & Ben-Baruch, A. The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer. Cancer Lett. 352, 36–53 (2014).
  CAS PubMed Google Scholar
• Levine, B., Mizushima, N. & Virgin, H. W. Autophagy in immunity and inflammation. Nature 469, 323–335 (2011).
  CAS PubMed PubMed Central Google Scholar
• White, E., Karp, C., Strohecker, A. M., Guo, Y. & Mathew, R. Role of autophagy in suppression of inflammation and cancer. Curr. Opin. Cell Biol. 22, 212–217 (2010).
  CAS PubMed PubMed Central Google Scholar
• Zhong, Z., Sanchez-Lopez, E. & Karin, M. Autophagy, inflammation, and immunity: a troika governing cancer and its treatment. Cell 166, 288–298 (2016).
  CAS PubMed PubMed Central Google Scholar
• Salminen, A., Hyttinen, J. M., Kauppinen, A. & Kaarniranta, K. Context-dependent regulation of autophagy by IKK-NF-κB signaling: impact on the aging process. Int. J. Cell Biol. 2012, 849541 (2012).
  PubMed PubMed Central Google Scholar
• Baldwin, A. S. Regulation of cell death and autophagy by IKK and NF-κB: critical mechanisms in immune function and cancer. Immunol. Rev. 246, 327–345 (2012).
  PubMed Google Scholar
• Copetti, T., Bertoli, C., Dalla, E., Demarchi, F. & Schneider, C. p65/RelA modulates BECN1 transcription and autophagy. Mol. Cell. Biol. 29, 2594–2608 (2009).
  CAS PubMed PubMed Central Google Scholar
• Ren, J. L., Pan, J. S., Lu, Y. P., Sun, P. & Han, J. Inflammatory signaling and cellular senescence. Cell Signal. 21, 378–383 (2009).
  CAS PubMed Google Scholar
• Capece, D. et al. Cancer secretome and inflammation: the bright and the dark sides of NF-κB. Semin. Cell Dev. Biol. https://doi.org/10.1016/j.semcdb.2017.08.004 (2017).
  CAS Google Scholar
• Yoshimoto, S. et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499, 97–101 (2013).
  CAS PubMed Google Scholar
• Jing, H. & Lee, S. NF-κB in cellular senescence and cancer treatment. Mol. Cells 37, 189–195 (2014).
  PubMed PubMed Central Google Scholar
• Chien, Y. et al. Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity. Genes Dev. 25, 2125–2136 (2011).
  CAS PubMed PubMed Central Google Scholar
• Soria-Valles, C. et al. NF-κB activation impairs somatic cell reprogramming in ageing. Nat. Cell Biol. 17, 1004–1013 (2015).
  CAS PubMed Google Scholar
• Pesic, M. & Greten, F. R. Inflammation and cancer: tissue regeneration gone awry. Curr. Opin. Cell Biol. 43, 55–61 (2016).
  CAS PubMed Google Scholar
• Su, T. et al. Two-signal requirement for growth-promoting function of Yap in hepatocytes. eLife 4, e02948 (2015).
  PubMed Central Google Scholar
• Chen, Q. et al. Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAP. Genes Dev. 29, 1285–1297 (2015).
  PubMed PubMed Central Google Scholar
• Maeda, S., Kamata, H., Luo, J. L., Leffert, H. & Karin, M. IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121, 977–990 (2005).
  CAS PubMed Google Scholar
• Yamada, Y., Kirillova, I., Peschon, J. J. & Fausto, N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc. Natl Acad. Sci. USA 94, 1441–1446 (1997).
  CAS PubMed PubMed Central Google Scholar
• Cressman, D. E. et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274, 1379–1383 (1996).
  CAS PubMed Google Scholar
• Dvorak, H. F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315, 1650–1659 (1986).
  CAS PubMed Google Scholar
• Shigdar, S. et al. Inflammation and cancer stem cells. Cancer Lett. 345, 271–278 (2014).
  CAS PubMed Google Scholar
• Tanno, T. & Matsui, W. Development and maintenance of cancer stem cells under chronic inflammation. J. Nippon Med. Sch. 78, 138–145 (2011).
  CAS PubMed PubMed Central Google Scholar
• Blaylock, R. L. Cancer microenvironment, inflammation and cancer stem cells: A hypothesis for a paradigm change and new targets in cancer control. Surg. Neurol. Int. 6, 92 (2015).
  PubMed PubMed Central Google Scholar
• Vazquez-Santillan, K., Melendez-Zajgla, J., Jimenez-Hernandez, L., Martinez-Ruiz, G. & Maldonado, V. NF-κB signaling in cancer stem cells: a promising therapeutic target? Cell Oncol. 38, 327–339 (2015).
  CAS Google Scholar
• Rinkenbaugh, A. L. & Baldwin, A. S. The NF-κB pathway and cancer stem cells. Cells 5, 16 (2016).
  PubMed Central Google Scholar
• Wu, Y. & Zhou, B. P. Inflammation: a driving force speeds cancer metastasis. Cell Cycle 8, 3267–3273 (2009).
  CAS PubMed Google Scholar
• Miao, J. W., Liu, L. J. & Huang, J. Interleukin-6-induced epithelial-mesenchymal transition through signal transducer and activator of transcription 3 in human cervical carcinoma. Int. J. Oncol. 45, 165–176 (2014).
  CAS PubMed Google Scholar
• Wendt, M. K., Balanis, N., Carlin, C. R. & Schiemann, W. P. STAT3 and epithelial-mesenchymal transitions in carcinomas. JAKSTAT 3, e28975 (2014).
  PubMed PubMed Central Google Scholar
• Yamamoto, M. et al. NF-κB non-cell-autonomously regulates cancer stem cell populations in the basal-like breast cancer subtype. Nat. Commun. 4, 2299 (2013).
  PubMed Google Scholar
• Sun, L. et al. Epigenetic regulation of SOX9 by the NF-κB signaling pathway in pancreatic cancer stem cells. Stem Cells 31, 1454–1466 (2013).
  CAS PubMed PubMed Central Google Scholar
• Baker, R. G., Hayden, M. S. & Ghosh, S. NF-κB, inflammation, and metabolic disease. Cell Metab. 13, 11–22 (2011).
  CAS PubMed PubMed Central Google Scholar
• Johnson, R. F. & Perkins, N. D. Nuclear factor-κB, p53, and mitochondria: regulation of cellular metabolism and the Warburg effect. Trends Biochem. Sci. 37, 317–324 (2012).
  CAS PubMed Google Scholar
• Xia, Y., Shen, S. & Verma, I. M. NF-κB, an active player in human cancers. Cancer Immunol. Res. 2, 823–830 (2014).
  CAS PubMed PubMed Central Google Scholar
• Liu, J. et al. Inflammation Improves Glucose Homeostasis through IKKβ-XBP1s Interaction. Cell 167, 1052–1066 (2016).
  CAS PubMed PubMed Central Google Scholar
• Mauro, C. et al. NF-κB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration. Nat. Cell Biol. 13, 1272–1279 (2011). This study shows that NF-κB plays an important role in metabolic adaptation in normal cells and in cancer cells.
  CAS PubMed PubMed Central Google Scholar
• Kawauchi, K. Araki, K., Tobiume, K. and Tanaka, N. p53 regulates glucose metabolism through an IKK-NF-κB pathway and inhibits cell transformation. Nat. Cell Biol. 10, 611–618 (2008).
  CAS PubMed Google Scholar
• Kawauchi, K., Araki, K., Tobiume, K. & Tanaka, N. Loss of p53 enhances catalytic activity of IKKbeta through O-linked β-N-acetyl glucosamine modification. Proc. Natl Acad. Sci. USA 106, 3431–3436 (2009).
  CAS PubMed PubMed Central Google Scholar
• Pitot, H. C., Goldsworthy, T. & Moran, S. The natural history of carcinogenesis: implications of experimental carcinogenesis in the genesis of human cancer. J. Supramol. Struct. Cell Biochem. 17, 133–146 (1981).
  CAS PubMed Google Scholar
• Barcellos-Hoff, M. H., Lyden, D. & Wang, T. C. The evolution of the cancer niche during multistage carcinogenesis. Nat. Rev. Cancer 13, 511–518 (2013).
  CAS PubMed Google Scholar
• Fearon, E. R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759–767 (1990).
  CAS PubMed Google Scholar
• Joyce, D. et al. NF-κB and cell-cycle regulation: the cyclin connection. Cytokine Growth Factor Rev. 12, 73–90 (2001).
  CAS PubMed Google Scholar
• Kiraly, O., Gong, G., Olipitz, W., Muthupalani, S. & Engelward, B. P. Inflammation-induced cell proliferation potentiates DNA damage-induced mutations in vivo. PLoS Genet. 11, e1004901 (2015).
  PubMed PubMed Central Google Scholar
• Colotta, F., Allavena, P., Sica, A., Garlanda, C. & Mantovani, A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30, 1073–1081 (2009).
  CAS PubMed Google Scholar
• Ren, J., Wang, Y., Gao, Y., Mehta, S.B. & Lee, C.G. FAT10 mediates the effect of TNF-α in inducing chromosomal instability. J. Cell Sci. 124, 3665–3675 (2011).
  CAS PubMed Google Scholar
• Vento-Tormo, R. et al. NF-κB directly mediates epigenetic deregulation of common microRNAs in Epstein–Barr virus-mediated transformation of B-cells and in lymphomas. Nucleic Acids Res. 42, 11025–11039 (2014).
  CAS PubMed PubMed Central Google Scholar
• Nakshatri, H. et al. NF-κB-dependent and -independent epigenetic modulation using the novel anti-cancer agent DMAPT. Cell Death Dis. 6, e1608 (2015).
  CAS PubMed PubMed Central Google Scholar
• Shimizu, T., Marusawa, H., Endo, Y. & Chiba, T. Inflammation-mediated genomic instability: roles of activation-induced cytidine deaminase in carcinogenesis. Cancer Sci. 103, 1201–1206 (2012).
  CAS PubMed PubMed Central Google Scholar
• Park, S. R. Activation-induced cytidine deaminase in B cell immunity and cancers. Immune Netw. 12, 230–239 (2012).
  CAS PubMed PubMed Central Google Scholar
• Seplyarskiy, V. B. et al. APOBEC-induced mutations in human cancers are strongly enriched on the lagging DNA strand during replication. Genome Res. 26, 174–182 (2016).
  CAS PubMed PubMed Central Google Scholar
• Leonard, B. et al. The PKC/NF-κB signaling pathway induces APOBEC3B expression in multiple human cancers. Cancer Res. 75, 4538–4547 (2015).
  CAS PubMed PubMed Central Google Scholar
• Maruyama, W. et al. Classical NF-κB pathway is responsible for APOBEC3B expression in cancer cells. Biochem. Biophys. Res. Commun. 478, 1466–1471 (2016).
  CAS PubMed Google Scholar
• Gudkov, A. V., Gurova, K. V. & Komarova, E. A. Inflammation and p53: A Tale of Two Stresses. Genes Cancer 2, 503–516 (2011).
  CAS PubMed PubMed Central Google Scholar
• Joneson, T. & Bar-Sagi, D. Suppression of Ras-induced apoptosis by the Rac GTPase. Mol. Cell. Biol. 19, 5892–5901 (1999).
  CAS PubMed PubMed Central Google Scholar
• You, Z., Madrid, L. V., Saims, D., Sedivy, J. & Wang, C. Y. c-Myc sensitizes cells to tumor necrosis factor-mediated apoptosis by inhibiting nuclear factor κB transactivation. J. Biol. Chem. 277, 36671–36677 (2002).
  CAS PubMed Google Scholar
• Basseres, D. S., Ebbs, A., Levantini, E. & Baldwin, A. S. Requirement of the NF-κB subunit p65/RelA for K-Ras-induced lung tumorigenesis. Cancer Res. 70, 3537–3546 (2010).
  CAS PubMed PubMed Central Google Scholar
• Pires, B. R. et al. NF-κB Is Involved in the regulation of EMT genes in breast cancer cells. PLoS ONE 12, e0169622 (2017).
  PubMed PubMed Central Google Scholar
• Scheel, C. & Weinberg, R. A. Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin. Cancer Biol. 22, 396–403 (2012).
  CAS PubMed PubMed Central Google Scholar
• Huber, M. A. et al. NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J. Clin. Invest. 114, 569–581 (2004).
  CAS PubMed PubMed Central Google Scholar
• Psaila, B. & Lyden, D. The metastatic niche: adapting the foreign soil. Nat. Rev. Cancer 9, 285–293 (2009).
  CAS PubMed PubMed Central Google Scholar
• Huang, S., Pettaway, C. A., Uehara, H., Bucana, C. D. & Fidler, I. J. Blockade of NF-κB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene 20, 4188–4197 (2001).
  CAS PubMed Google Scholar
• Gorlach, A. & Bonello, S. The cross-talk between NF-κB and HIF-1: further evidence for a significant liaison. Biochem. J. 412, e17–19 (2008).
  PubMed Google Scholar
• Gilkes, D. M. & Semenza, G. L. Role of hypoxia-inducible factors in breast cancer metastasis. Future Oncol. 9, 1623–1636 (2013).
  CAS PubMed Google Scholar
• Zhang, W. et al. HIF-1α promotes epithelial-mesenchymal transition and metastasis through direct regulation of ZEB1 in colorectal cancer. PLoS ONE 10, e0129603 (2015).
  PubMed PubMed Central Google Scholar
• Drabsch, Y. & ten Dijke, P. TGF-β signalling and its role in cancer progression and metastasis. Cancer Metastasis Rev. 31, 553–568 (2012).
  CAS PubMed Google Scholar
• Kisseleva, T. et al. NF-κB regulation of endothelial cell function during LPS-induced toxemia and cancer. J. Clin. Invest. 116, 2955–2963 (2006).
  CAS PubMed PubMed Central Google Scholar
• Tabruyn, S. P. & Griffioen, A. W. NF-κB: a new player in angiostatic therapy. Angiogenesis 11, 101–106 (2008).
  CAS PubMed PubMed Central Google Scholar
• Costa, C., Incio, J. & Soares, R. Angiogenesis and chronic inflammation: cause or consequence? Angiogenesis 10, 149–166 (2007).
  PubMed Google Scholar
• Spina, A. et al. HGF/c-MET axis in tumor microenvironment and metastasis formation. Biomedicines 3, 71–88 (2015).
  CAS PubMed PubMed Central Google Scholar
• Balkwill, F. Cancer and the chemokine network. Nat. Rev. Cancer 4, 540–550 (2004).
  CAS PubMed Google Scholar
• Grivennikov, S. et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15, 103–113 (2009).
  CAS PubMed PubMed Central Google Scholar
• Bollrath, J. et al. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell 15, 91–102 (2009).
  CAS PubMed Google Scholar
• Tosolini, M. et al. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, Th2, Treg, Th17) in patients with colorectal cancer. Cancer Res. 71, 1263–1271 (2011).
  CAS PubMed Google Scholar
• Schetter, A. J. et al. Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma. Clin. Cancer Res. 15, 5878–5887 (2009).
  CAS PubMed PubMed Central Google Scholar
• Hinoi, T. et al. Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation. Cancer Res. 67, 9721–9730 (2007).
  CAS PubMed Google Scholar
• Fearnhead, N. S., Britton, M. P. & Bodmer, W. F. The ABC of APC. Hum. Mol. Genet. 10, 721–733 (2001).
  CAS PubMed Google Scholar
• Ulrich, C. M., Bigler, J. & Potter, J. D. Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics. Nat. Rev. Cancer 6, 130–140 (2006).
  CAS PubMed Google Scholar
• Guma, M. et al. Constitutive intestinal NF-κB does not trigger destructive inflammation unless accompanied by MAPK activation. J. Exp. Med. 208, 1889–1900 (2011).
  CAS PubMed PubMed Central Google Scholar
• Shaked, H. et al. Chronic epithelial NF-κB activation accelerates APC loss and intestinal tumor initiation through iNOS up-regulation. Proc. Natl Acad. Sci. USA 109, 14007–14012 (2012).
  CAS PubMed PubMed Central Google Scholar
• Vlantis, K. et al. Constitutive IKK2 activation in intestinal epithelial cells induces intestinal tumors in mice. J. Clin. Invest. 121, 2781–2793 (2011).
  CAS PubMed PubMed Central Google Scholar
• Myant, K. B. et al. ROS production and NF-κB activation triggered by RAC1 facilitate WNT-driven intestinal stem cell proliferation and colorectal cancer initiation. Cell Stem Cell 12, 761–773 (2013).
  CAS PubMed PubMed Central Google Scholar
• Mittal, S. & El-Serag, H. B. Epidemiology of hepatocellular carcinoma: consider the population. J. Clin. Gastroenterol. 47 (Suppl.), S2–S6 (2013).
  PubMed PubMed Central Google Scholar
• Mauad, T. H. et al. Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis. Am. J. Pathol. 145, 1237–1245 (1994).
  CAS PubMed PubMed Central Google Scholar
• Kong, L. et al. Deletion of interleukin-6 in monocytes/macrophages suppresses the initiation of hepatocellular carcinoma in mice. J. Exp. Clin. Cancer Res. 35, 131 (2016).
  PubMed PubMed Central Google Scholar
• Sakurai, T. et al. Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis. Cancer Cell 14, 156–165 (2008).
  CAS PubMed PubMed Central Google Scholar
• He, G. et al. Hepatocyte IKKbeta/NF-κB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation. Cancer Cell 17, 286–297 (2010).
  CAS PubMed PubMed Central Google Scholar
• Nakagawa, H. et al. ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development. Cancer Cell 26, 331–343 (2014).
  CAS PubMed PubMed Central Google Scholar
• Park, E. J. et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140, 197–208 (2010). References 192 and 193 reveal the importance of TNF-mediated NF-κB signalling in obesity-associated HCC.
  CAS PubMed PubMed Central Google Scholar
• Luedde, T. et al. Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell 11, 119–132 (2007).
  CAS PubMed Google Scholar
• Kondylis, V. et al. NEMO prevents steatohepatitis and hepatocellular carcinoma by inhibiting RIPK1 kinase activity-mediated hepatocyte apoptosis. Cancer Cell 28, 582–598 (2015).
  CAS PubMed PubMed Central Google Scholar
• Naugler, W. E. et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317, 121–124 (2007).
  CAS PubMed Google Scholar
• Stein, B. & Yang, M. X. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-κB and C/EBPβ. Mol. Cell. Biol. 15, 4971–4979 (1995).
  CAS PubMed PubMed Central Google Scholar
• Galien, R. & Garcia, T. Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-κB site. Nucleic Acids Res. 25, 2424–2429 (1997).
  CAS PubMed PubMed Central Google Scholar
• Liu, H., Liu, K. & Bodenner, D. L. Estrogen receptor inhibits interleukin-6 gene expression by disruption of nuclear factor κB transactivation. Cytokine 31, 251–257 (2005).
  CAS PubMed Google Scholar
• Wang, H. et al. Hepatoprotective versus oncogenic functions of STAT3 in liver tumorigenesis. Am. J. Pathol. 179, 714–724 (2011).
  CAS PubMed PubMed Central Google Scholar
• Finkin, S. et al. Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma. Nat. Immunol. 16, 1235–1244 (2015). This study shows that constitutive activation of NF-κB in hepatocytes results in HCC development.
  CAS PubMed PubMed Central Google Scholar
• Pitzalis, C., Jones, G. W., Bombardieri, M. & Jones, S. A. Ectopic lymphoid-like structures in infection, cancer and autoimmunity. Nat. Rev. Immunol. 14, 447–462 (2014).
  CAS PubMed Google Scholar
• Haybaeck, J. et al. A lymphotoxin-driven pathway to hepatocellular carcinoma. Cancer Cell 16, 295–308 (2009).
  CAS PubMed PubMed Central Google Scholar
• Khandekar, M. J., Cohen, P. & Spiegelman, B. M. Molecular mechanisms of cancer development in obesity. Nat. Rev. Cancer 11, 886–895 (2011).
  CAS PubMed Google Scholar
• Deng, T., Lyon, C. J., Bergin, S., Caligiuri, M. A. & Hsueh, W. A. Obesity, inflammation, and cancer. Annu. Rev. Pathol. 11, 421–449 (2016).
  CAS PubMed Google Scholar
• Gilbert, C. A. & Slingerland, J. M. Cytokines, obesity, and cancer: new insights on mechanisms linking obesity to cancer risk and progression. Annu. Rev. Med. 64, 45–57 (2013).
  CAS PubMed Google Scholar
• Bettermann, K., Hohensee, T. & Haybaeck, J. Steatosis and steatohepatitis: complex disorders. Int. J. Mol. Sci. 15, 9924–9944 (2014).
  CAS PubMed PubMed Central Google Scholar
• Weglarz, T. C., Degen, J. L. & Sandgren, E. P. Hepatocyte transplantation into diseased mouse liver. Kinetics of parenchymal repopulation and identification of the proliferative capacity of tetraploid and octaploid hepatocytes. Am. J. Pathol. 157, 1963–1974 (2000).
  CAS PubMed PubMed Central Google Scholar
• Shalapour, S. et al. Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity. Nature 551, 340–345 (2017).
  CAS PubMed PubMed Central Google Scholar
• Prabhu, L., Mundade, R., Korc, M., Loehrer, P. J. & Lu, T. Critical role of NF-κB in pancreatic cancer. Oncotarget 5, 10969–10975 (2014).
  PubMed PubMed Central Google Scholar
• Greer, J. B. & Whitcomb, D. C. Inflammation and pancreatic cancer: an evidence-based review. Curr. Opin. Pharmacol. 9, 411–418 (2009).
  CAS PubMed Google Scholar
• Fujioka, S. et al. Function of nuclear factor κB in pancreatic cancer metastasis. Clin. Cancer Res. 9, 346–354 (2003).
  CAS PubMed Google Scholar
• Dima, S. O. et al. An exploratory study of inflammatory cytokines as prognostic biomarkers in patients with ductal pancreatic adenocarcinoma. Pancreas 41, 1001–1007 (2012).
  CAS PubMed Google Scholar
• Ling, J. et al. KrasG12D-induced IKK2/β/NF-κB activation by IL-α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell 21, 105–120 (2012).
  CAS PubMed PubMed Central Google Scholar
• Ebrahimi, B., Tucker, S. L., Li, D., Abbruzzese, J. L. & Kurzrock, R. Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis. Cancer 101, 2727–2736 (2004).
  CAS PubMed Google Scholar
• Bellone, G. et al. Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival. Cancer Immunol. Immunother. 55, 684–698 (2006).
  CAS PubMed Google Scholar
• Bryant, K. L., Mancias, J. D., Kimmelman, A. C. & Der, C. J. KRAS: feeding pancreatic cancer proliferation. Trends Biochem. Sci. 39, 91–100 (2014).
  CAS PubMed PubMed Central Google Scholar
• Maniati, E. et al. Crosstalk between the canonical NF-κB and Notch signaling pathways inhibits Pparγ expression and promotes pancreatic cancer progression in mice. J. Clin. Invest. 121, 4685–4699 (2011).
  CAS PubMed PubMed Central Google Scholar
• Lesina, M. et al. Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer. Cancer Cell 19, 456–469 (2011).
  CAS PubMed Google Scholar
• Khasawneh, J. et al. Inflammation and mitochondrial fatty acid beta-oxidation link obesity to early tumor promotion. Proc. Natl Acad. Sci. USA 106, 3354–3359 (2009).
  CAS PubMed PubMed Central Google Scholar
• Li, N. et al. Loss of acinar cell IKKalpha triggers spontaneous pancreatitis in mice. J. Clin. Invest. 123, 2231–2243 (2013).
  CAS PubMed PubMed Central Google Scholar
• Todoric, J. A. et al. Stress activated NRF2-MDM2 cascade controls neoplastic progression in pancreas. Cancer Cell 32, 824–839 (2017).
  CAS PubMed PubMed Central Google Scholar
• Sfanos, K. S. & De Marzo, A. M. Prostate cancer and inflammation: the evidence. Histopathology 60, 199–215 (2012).
  PubMed PubMed Central Google Scholar
• Rajasekhar, V. K., Studer, L., Gerald, W., Socci, N. D. & Scher, H. I. Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signalling. Nat. Commun. 2, 162 (2011).
  PubMed Google Scholar
• Jin, R. et al. NF-κB gene signature predicts prostate cancer progression. Cancer Res. 74, 2763–2772 (2014).
  CAS PubMed PubMed Central Google Scholar
• Tse, B. W., Scott, K. F. & Russell, P. J. Paradoxical roles of tumour necrosis factor-alpha in prostate cancer biology. Prostate Cancer 2012, 128965 (2012).
  PubMed PubMed Central Google Scholar
• Nguyen, D. P., Li, J. & Tewari, A. K. Inflammation and prostate cancer: the role of interleukin 6 (IL-6). BJU Int. 113, 986–992 (2014).
  CAS PubMed Google Scholar
• Luo, J. L. et al. Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin. Nature 446, 690–694 (2007).
  CAS PubMed Google Scholar
• Diamanti, M. A. et al. IKKalpha controls ATG16L1 degradation to prevent ER stress during inflammation. J. Exp. Med. 214, 423–437 (2017).
  CAS PubMed PubMed Central Google Scholar
• Chen, W., Li, Z., Bai, L. & Lin, Y. NF-κB in lung cancer, a carcinogenesis mediator and a prevention and therapy target. Front. Biosci. 16, 1172–1185 (2011).
  CAS PubMed Central Google Scholar
• Cai, Z., Tchou-Wong, K. M. & Rom, W. N. NF-κB in lung tumorigenesis. Cancers 3, 4258–4268 (2011).
  CAS PubMed PubMed Central Google Scholar
• Mizuno, S. et al. Chronic obstructive pulmonary disease and interstitial lung disease in patients with lung cancer. Respirology 14, 377–383 (2009).
  PubMed Google Scholar
• Tang, X. et al. Nuclear factor-κB (NF-κB) is frequently expressed in lung cancer and preneoplastic lesions. Cancer 107, 2637–2646 (2006).
  CAS PubMed Google Scholar
• Takahashi, H., Ogata, H., Nishigaki, R., Broide, D. H. & Karin, M. Tobacco smoke promotes lung tumorigenesis by triggering IKKβ- and JNK1-dependent inflammation. Cancer Cell 17, 89–97 (2010).
  CAS PubMed PubMed Central Google Scholar
• Meylan, E. et al. Requirement for NF-κB signalling in a mouse model of lung adenocarcinoma. Nature 462, 104–107 (2009).
  CAS PubMed PubMed Central Google Scholar
• Duran, A. et al. The signaling adaptor p62 is an important NF-κB mediator in tumorigenesis. Cancer Cell 13, 343–354 (2008).
  CAS PubMed Google Scholar
• Bivona, T. G. et al. FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR. Nature 471, 523–526 (2011).
  CAS PubMed PubMed Central Google Scholar
• Blakely, C. M. et al. NF-κB-activating complex engaged in response to EGFR oncogene inhibition drives tumor cell survival and residual disease in lung cancer. Cell Rep. 11, 98–110 (2015).
  CAS PubMed PubMed Central Google Scholar
• Tohme, S., Simmons, R. L. & Tsung, A. Surgery for cancer: a trigger for metastases. Cancer Res. 77, 1548–1552 (2017). This is an excellent review that explains how surgery affects cancer metastasis.
  CAS PubMed PubMed Central Google Scholar
• Segatto, I. et al. Surgery-induced wound response promotes stem-like and tumor-initiating features of breast cancer cells, via STAT3 signaling. Oncotarget 5, 6267–6279 (2014).
  PubMed PubMed Central Google Scholar
• Godwin, P. et al. Targeting nuclear factor-kappa B to overcome resistance to chemotherapy. Front. Oncol. 3, 120 (2013).
  CAS PubMed PubMed Central Google Scholar
• Wang, W., Mani, A. M. & Wu, Z. H. DNA damage-induced nuclear factor-kappa B activation and its roles in cancer progression. J. Cancer Metastasis Treat. 3, 45–49 (2017).
  CAS PubMed PubMed Central Google Scholar
• Korkaya, H. et al. Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population. Mol. Cell 47, 570–584 (2012).
  CAS PubMed PubMed Central Google Scholar
• Zitvogel, L., Apetoh, L., Ghiringhelli, F. & Kroemer, G. Immunological aspects of cancer chemotherapy. Nat. Rev. Immunol. 8, 59–73 (2008).
  CAS PubMed Google Scholar
• Peng, J. et al. Chemotherapy induces programmed cell death-ligand 1 overexpression via the nuclear factor-κB to foster an immunosuppressive tumor microenvironment in ovarian cancer. Cancer Res. 75, 5034–5045 (2015).
  CAS PubMed Google Scholar
• Wang, W., Tam, W. F., Hughes, C. C., Rath, S. & Sen, R. c-Rel is a target of pentoxifylline-mediated inhibition of T lymphocyte activation. Immunity 6, 165–174 (1997).
  CAS PubMed Google Scholar
• Lin, Y., Bai, L., Chen, W. & Xu, S. The NF-κB activation pathways, emerging molecular targets for cancer prevention and therapy. Expert Opin. Ther. Targets 14, 45–55 (2010).
  CAS PubMed PubMed Central Google Scholar
• Gurpinar, E., Grizzle, W. E. & Piazza, G. A. NSAIDs inhibit tumorigenesis, but how? Clin. Cancer Res. 20, 1104–1113 (2014).
  CAS PubMed Google Scholar
• Hsu, L. C. et al. IL-1β-driven neutrophilia preserves antibacterial defense in the absence of the kinase IKKβ. Nat. Immunol. 12, 144–150 (2011).
  CAS PubMed Google Scholar
• Storz, P. Targeting the alternative NF-κB pathway in pancreatic cancer: a new direction for therapy? Expert Rev. Anticancer Ther. 13, 501–504 (2013).
  CAS PubMed PubMed Central Google Scholar
• Yu, H., Kortylewski, M. & Pardoll, D. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat. Rev. Immunol. 7, 41–51 (2007).
  CAS PubMed Google Scholar
• Ferguson, S. D., Srinivasan, V. M. & Heimberger, A. B. The role of STAT3 in tumor-mediated immune suppression. J. Neurooncol. 123, 385–394 (2015).
  CAS PubMed Google Scholar
• Hillmer, E. J., Zhang, H., Li, H. S. & Watowich, S. S. STAT3 signaling in immunity. Cytokine Growth Factor Rev. 31, 1–15 (2016).
  PubMed PubMed Central Google Scholar
• Haynes, K. et al. Tumor necrosis factor α inhibitor therapy and cancer risk in chronic immune-mediated diseases. Arthritis Rheum. 65, 48–58 (2013).
  CAS PubMed Google Scholar
• Rubbert-Roth, A. et al. Malignancy rates in patients with rheumatoid arthritis treated with tocilizumab. RMD Open 2, e000213 (2016).
  PubMed PubMed Central Google Scholar
• Winthrop, K. L. The emerging safety profile of JAK inhibitors in rheumatic disease. Nat. Rev. Rheumatol 13, 234–243 (2017).
  CAS PubMed Google Scholar
• Wardill, H. R., Bowen, J. M. & Gibson, R. J. New pharmacotherapy options for chemotherapy-induced alimentary mucositis. Expert Opin. Biol. Ther. 14, 347–354 (2014).
  CAS PubMed Google Scholar
• Tanaka, T., Narazaki, M. & Kishimoto, T. Therapeutic targeting of the interleukin-6 receptor. Annu. Rev. Pharmacol. Toxicol. 52, 199–219 (2012).
  CAS PubMed Google Scholar
• Hoesel, B. & Schmid, J. A. The complexity of NF-κB signaling in inflammation and cancer. Mol. Cancer 12, 86 (2013).
  CAS PubMed PubMed Central Google Scholar
• Garner, J. M. et al. Constitutive activation of signal transducer and activator of transcription 3 (STAT3) and nuclear factor κB signaling in glioblastoma cancer stem cells regulates the Notch pathway. J. Biol. Chem. 288, 26167–26176 (2013).
  CAS PubMed PubMed Central Google Scholar
• Hagemann, T., Biswas, S. K., Lawrence, T., Sica, A. & Lewis, C. E. Regulation of macrophage function in tumors: the multifaceted role of NF-kappaB. Blood 113, 3139–3146 (2009).
  CAS PubMed Google Scholar
• Gudkov, A. V. & Komarova, E. A. p53 and the carcinogenicity of chronic inflammation. Cold Spring Harb. Perspect. Med. https://doi.org/10.1101/cshperspect.a026161 (2016).
  PubMed PubMed Central Google Scholar
• Xia, Y. et al. Phosphorylation of p53 by IκB kinase 2 promotes its degradation by β-TrCP. Proc. Natl Acad. Sci. USA 106, 2629–2634 (2009).
  CAS PubMed PubMed Central Google Scholar
• Cooks, T. et al. Mutant p53 prolongs NF-κB activation and promotes chronic inflammation and inflammation-associated colorectal cancer. Cancer Cell 23, 634–646 (2013).
  CAS PubMed PubMed Central Google Scholar
• Pasparakis, M. Role of NF-κB in epithelial biology. Immunol. Rev. 246, 346–358 (2012).
  PubMed Google Scholar
• Honda, K. & Taniguchi, T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 6, 644–658 (2006).
  CAS PubMed Google Scholar
• Iwanaszko, M. & Kimmel, M. NF-κB and IRF pathways: cross-regulation on target genes promoter level. BMC Genomics 16, 307 (2015).
  PubMed PubMed Central Google Scholar
• Wietek, C., Miggin, S. M., Jefferies, C. A. & O'Neill, L. A. Interferon regulatory factor-3-mediated activation of the interferon-sensitive response element by Toll-like receptor (TLR) 4 but not TLR3 requires the p65 subunit of NF-kappa. J. Biol. Chem. 278, 50923–50931 (2003).
  CAS PubMed Google Scholar
• Han, K. J. et al. Mechanisms of the TRIF-induced interferon-stimulated response element and NF-κB activation and apoptosis pathways. J. Biol. Chem. 279, 15652–15661 (2004).
  CAS PubMed Google Scholar
• Covert, M. W., Leung, T. H., Gaston, J. E. & Baltimore, D. Achieving stability of lipopolysaccharide-induced NF-κB activation. Science 309, 1854–1857 (2005).
  CAS PubMed Google Scholar
• Zitvogel, L., Galluzzi, L., Kepp, O., Smyth, M. J. & Kroemer, G. Type I interferons in anticancer immunity. Nat. Rev. Immunol. 15, 405–414 (2015).
  CAS PubMed Google Scholar
• Wardyn, J. D., Ponsford, A. H. & Sanderson, C. M. Dissecting molecular cross-talk between Nrf2 and NF-κB response pathways. Biochem. Soc. Trans. 43, 621–626 (2015).
  CAS PubMed PubMed Central Google Scholar
• Buelna-Chontal, M. & Zazueta, C. Redox activation of Nrf2 and NF-κB: a double end sword? Cell Signal. 25, 2548–2557 (2013).
  CAS PubMed Google Scholar
• Kohler, U. A. et al. NF-κB/RelA and Nrf2 cooperate to maintain hepatocyte integrity and to prevent development of hepatocellular adenoma. J. Hepatol. 64, 94–102 (2016).
  CAS PubMed Google Scholar
• Umemura, A. et al. p62, upregulated during preneoplasia, induces hepatocellular carcinogenesis by maintaining survival of stressed HCC-initiating cells. Cancer Cell 29, 935–948 (2016).
  CAS PubMed PubMed Central Google Scholar
• Papa, S., Zazzeroni, F., Pham, C. G., Bubici, C. & Franzoso, G. Linking JNK signaling to NF-κB: a key to survival. J. Cell Sci. 117, 5197–5208 (2004).
  CAS PubMed Google Scholar
• Sakurai, T., Maeda, S., Chang, L. & Karin, M. Loss of hepatic NF-κB activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation. Proc. Natl Acad. Sci. USA 103, 10544–10551 (2006).
  CAS PubMed PubMed Central Google Scholar
• Ma, B. & Hottiger, M. O. Crosstalk between Wnt/β-catenin and NF-κB signaling pathway during inflammation. Front. Immunol. 7, 378 (2016).
  PubMed PubMed Central Google Scholar
• Schwitalla, S. et al. Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell 152, 25–38 (2013).
  CAS PubMed Google Scholar
• Ang, H. L. & Tergaonkar, V. Notch and NFκB signaling pathways: Do they collaborate in normal vertebrate brain development and function? Bioessays 29, 1039–1047 (2007).
  CAS PubMed Google Scholar
• Francescone, R., Hou, V. & Grivennikov, S. I. Microbiome, inflammation, and cancer. Cancer J. 20, 181–189 (2014).
  CAS PubMed PubMed Central Google Scholar
• Roy, S. & Trinchieri, G. Microbiota: a key orchestrator of cancer therapy. Nat. Rev. Cancer 17, 271–285 (2017).
  CAS PubMed Google Scholar
• Dzutsev, A. et al. Microbes and cancer. Annu. Rev. Immunol. 35, 199–228 (2017).
  CAS PubMed Google Scholar
• Dzutsev, A., Goldszmid, R. S., Viaud, S., Zitvogel, L. & Trinchieri, G. The role of the microbiota in inflammation, carcinogenesis, and cancer therapy. Eur. J. Immunol. 45, 17–31 (2015).
  CAS PubMed Google Scholar
• Gopalakrishnan, V. et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science https://doi.org/10.1126/science.aan4236 (2017).
  PubMed PubMed Central Google Scholar
• Routy, B. et al. Gut microbiome influences efficacy of PD-1 based immunotherapy against epithelial tumors. Science https://doi.org/10.1126/science.aan3706 (2017).
  PubMed Google Scholar
• Yu, L. C., Wang, J. T., Wei, S. C. & Ni, Y. H. Host-microbial interactions and regulation of intestinal epithelial barrier function: from physiology to pathology. World J. Gastrointestinal Pathophysiol. 3, 27–43 (2012).
  Google Scholar
• Schwabe, R. F. & Jobin, C. The microbiome and cancer. Nat. Rev. Cancer 13, 800–812 (2013).
  CAS PubMed PubMed Central Google Scholar
• Vemuri, R. C., Gundamaraju, R., Shinde, T. & Eri, R. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation? Benef Microbes 8, 179–192 (2017).
  CAS PubMed Google Scholar
• Brennan, C. A. & Garrett, W. S. Gut Microbiota, Inflammation, and Colorectal Cancer. Annu. Rev. Microbiol. 70, 395–411 (2016).
  CAS PubMed PubMed Central Google Scholar
• Sun, J. & Kato, I. Gut microbiota, inflammation and colorectal cancer. Genes Dis. 3, 130–143 (2016).
  PubMed PubMed Central Google Scholar
• Furusawa, Y. et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504, 446–450 (2013).
  CAS PubMed Google Scholar
• Arpaia, N. et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504, 451–455 (2013).
  CAS PubMed PubMed Central Google Scholar
• Tanoue, T., Atarashi, K. & Honda, K. Development and maintenance of intestinal regulatory T cells. Nat. Rev. Immunol. 16, 295–309 (2016).
  CAS PubMed Google Scholar
• Honda, K. & Littman, D. R. The microbiota in adaptive immune homeostasis and disease. Nature 535, 75–84 (2016).
  CAS PubMed Google Scholar